Prospective Evaluation of MicroMatrix® Flex in Wounds Complicated by Tunneling and Undermining
To evaluate the safety and performance of MicroMatrix® Flex in subjects with wounds complicated by tunneling and/or undermining features.
• Patient is ≥ 22 years at the time of consent
• Patient with a diagnosis of pressure injury, venous ulcer, diabetic ulcer, necrotizing soft tissue infection associated wound, dehiscing and/or draining wounds associated with open abdominal procedures, or any indication per the Instructions For Use
• Patient is willing and able to adhere to protocol requirements and comply with the study follow-up regimen
• Patient has reviewed the IRB/IEC-approved consent form, has been properly consented per the protocol and has documented their consent to participate in the study by signing the IRB/IEC-approved consent form